Copyright
©The Author(s) 2023.
World J Gastrointest Surg. Sep 27, 2023; 15(9): 1919-1931
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1919
Published online Sep 27, 2023. doi: 10.4240/wjgs.v15.i9.1919
Table 4 The serum total bilirubin levels in control and intervention groups before and after autologous bone marrow infusion
| Group | Before | 1 mo | t/P value | 3 mo | t/P value | 6 mo | t/P value | 12 mo | t/P value |
| Control | 44.89 ± 20.56 | 35.11 ± 15.20 | 6.536/0.000 | 29.95 ± 12.69 | 7.379/0.000 | 27.26 ± 11.77 | 7.896/0.000 | 24.29 ± 8.57 | 8.255/0.000 |
| Intervention | 42.90 ± 19.77 | 31.48 ± 14.12 | 7.534/0.000 | 27.58 ± 12.55 | 9.014/0.000 | 26.05 ± 11.02 | 9.021/0.000 | 23.65 ± 8.44 | 9.120/0.000 |
| t | 0.437 | 1.093 | 0.830 | 0.470 | 0.332 | ||||
| P value | 0.663 | 0.278 | 0.409 | 0.640 | 0.741 |
- Citation: Liu BC, Cheng MR, Lang L, Li L, Si YH, Li AJ, Xu Q, Zhang H. Autologous bone marrow infusion via portal vein combined with splenectomy for decompensated liver cirrhosis: A retrospective study. World J Gastrointest Surg 2023; 15(9): 1919-1931
- URL: https://www.wjgnet.com/1948-9366/full/v15/i9/1919.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v15.i9.1919